MULTAQ

This brand name is authorized in United States. It is also authorized in Austria, Canada, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Poland, Singapore, Spain, UK.

Active ingredients

The drug MULTAQ contains one active pharmaceutical ingredient (API):

1	Dronedarone UNII FA36DV299Q - DRONEDARONE HYDROCHLORIDE
	Dronedarone is a multichannel blocker inhibiting the potassium currents (including IK(Ach), IKur, IKr, IKs) and thus prolonging cardiac action potential and refractory periods (Class III). It also inhibits the sodium currents (Class Ib) and the calcium currents (Class IV). It non-competitively antagonises adrenergic activities (Class II).
	Read more about Dronedarone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MULTAQ Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01BD07	Dronedarone	C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BD Antiarrhythmics, class III
Discover more medicines within C01BD07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02330989
EE	Ravimiamet	1454071, 1454082, 1454093, 1454105
ES	Centro de información online de medicamentos de la AEMPS	09591003
FI	Lääkealan turvallisuus- ja kehittämiskeskus	028022, 028034
FR	Base de données publique des médicaments	69213011
GB	Medicines & Healthcare Products Regulatory Agency	170665, 170666, 196968
HK	Department of Health Drug Office	59499
IE	Health Products Regulatory Authority	32621, 32653
IL	מִשְׂרַד הַבְּרִיאוּת	6412
IT	Agenzia del Farmaco	039589039
LT	Valstybinė vaistų kontrolės tarnyba	1052579, 1052580, 1052581, 1052582
PL	Rejestru Produktów Leczniczych	100217050
SG	Health Sciences Authority	13849P
US	FDA, National Drug Code	0024-4142, 55154-8104